Joshua Teitelbaum serves as counsel in the public law and policy practice and advises clients across a diverse array of industries on issues related to trade and health policy, among others.
Practice & Background
Prior to joining Akin Gump Strauss Hauer & Feld LLP, Mr. Teitelbaum served as Deputy Assistant Secretary of Commerce for Textiles, Consumer Goods and Materials with the International Trade Administration in the U.S. Department of Commerce (DOC). While serving in this role, Mr. Teitelbaum was a policy-maker for, and public advocate of, the Obama administration’s highest international trade priorities. His work included substantial contributions to the development of the Trans-Pacific Partnership (TPP) agreement, the Trans-Atlantic Trade and Investment Partnership (TTIP) and the DOC’s implementation of the conflict minerals provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act, among other multilateral, regional and bilateral trade initiatives. His work spanned a broad cross section of U.S. industries, including textiles, apparel, home furnishings, processed foods, distilled spirits, recreational transportation, cosmetics, chemicals and building materials.
He also served as the chairman of the Committee for the Implementation of Textile Agreements, which supervises the negotiation and implementation of textile and apparel agreements.
Prior to his role at the DOC, Mr. Teitelbaum served as staff director for the U.S. Senate Health, Education, Labor and Pensions (HELP) Subcommittee on Children & Families; as legislative assistant to Sen. Kay Hagan (D-NC); and as legislative counsel to Rep. Steve Israel (D-NY), where he advised on a wide range of issues, including health care, education and financial services. Mr. Teitelbaum’s experience with health care policy, in support of members of both the House and Senate, includes navigating the passage and subsequent implementation of the Affordable Care Act as well as the FDA Safety and Innovation Act of 2012 to reauthorize and modify the review processes for drugs, devices and biologics. He worked closely with constituent health care providers including nursing and physician practices, hospital systems and patient advocates.
Mr. Teitelbaum received his J.D. from The George Washington University Law School in 2008 and his B.S. from Cornell University in 2005.